BYSI BeyondSpring
- 1.920
- +0.180+10.34%
BeyondSpring News
Express News | Beyondspring-After Series a-3 Financing 1St Close, Co, Seed Technology Limited to Own About 46.9% of Outstanding Equity Interest in Seedtherapeutics
Express News | Beyondspring Inc - Seed to File Ind for Tau Degrader Program in 2026
Express News | Seed Therapeutics Announces $1.5B Research Collaboration With Eisai
Express News | Seed Therapeutics (Seed) Enters Into Strategic Research Collaboration With Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
BeyondSpring Raises $3 Million via Stock Sale
Express News | Beyondspring Inc Files for Stock Shelf Offering of up to 10 Mln Ordinary Shares- SEC Filing
BeyondSpring (NASDAQ:BYSI) Shareholders Have Earned a 141% Return Over the Last Year
Express News | BeyondSpring Says It Will Host Virtual R&D Day To Discuss New Plinabulin Development Strategy For Cancer And Updates For Seed Therapeutics
Express News | BeyondSpring Reports FY23 Loss Per Share Of $(0.54) Vs. $(0.85) Last Year
Press Release: BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
BeyondSpring Files 2023 Annual Report on Form 20-F
Express News | Beyondspring Provides Business Update and Reports Year End 2023 Financial Results
IBio, Mesoblast, Kodiak Sciences Among Healthcare Movers
BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment
BeyondSpring Announces First Patient Dosed With Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
BeyondSpring Announces Executive Leadership Change
12 Health Care Stocks Moving In Thursday's Intraday Session
BeyondSpring, EnVVeno Medical, Aptorum Group Among Healthcare Movers
BYSI, PHUN and DTSS Among Pre-market Losers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Analysis
Price Target
No Data
